March 2018 HPV Vaccination Supplement
HPV Vaccination in Young Adults: Are We Doing Enough?
March 02, 2018
Article
Special Section: Immunizations & Vaccinations
Human papillomavirus (HPV) consists of a group of more than 150 related viruses, some of which have been identified as causes of certain types of cancer.
The Path Ahead for the HPV Vaccine
March 02, 2018
Article
Special Section: Immunizations & Vaccinations
The question of whether a state has the right to institute a mandatory vaccination policy against human papillomavirus (HPV) for school children remains hotly disputed.
Making HPV Vaccination Affordable for Patients
March 02, 2018
Article
Special Section: Immunizations & Vaccinations
Human papillomavirus infection (HPV) is a known cause for virtually all cases of cervical and anal cancers and about 70% of oropharyngeal cancer cases.
Year-Round Solutions Beyond the Influenza Season
March 02, 2018
Article
Special Section: Immunizations & Vaccinations
As the margin between acquisition cost and sales price continues to narrow for traditional community pharmacy medication dispensing, many pharmacies are increasingly turning to service-based opportunities to improve their profitability.
Dialogue and Education: Engaging Young Adults on the HPV Vaccine
March 02, 2018
Article
Special Section: Immunizations & Vaccinations
Vaccinations are often given to protect populations whose immune systems are most vulnerable, but pharmacists are aware that some vaccinations are also important during the adolescent and young-adult years.
Patient Communication Strategies for Boosting HPV Vaccination Coverage
March 02, 2018
Article
Special Section: Immunizations & Vaccinations
Pharmacists have long been considered among the most accessible and trusted health care advisers.
The 9-Valent HPV Recombinant Vaccine: An Introduction
March 01, 2018
Article
Special Section: Immunizations & Vaccinations
The 9-valent human papillomavirus (HPV) recombinant vaccine (Gardasil 9, Merck & Company, Inc.) is indicated for women and men aged 9 to 26 years for the prevention of certain diseases, precancerous lesions, and genital warts caused by HPV.